ストックスクリーナーアプリを入手
2.11
4.09%
-0.09
アフターアワーズ：
2.11
前日終値:
$2.20
開ける：
$2.15
24時間の取引高:
455.99K
Relative Volume:
0.33
時価総額：
$131.27M
収益：
-
当期純損益:
$-117.50M
株価収益率:
-0.8792
EPS:
-2.4
ネットキャッシュフロー:
$-114.31M
1週間 パフォーマンス:
+16.57%
1か月 パフォーマンス:
+47.55%
6か月 パフォーマンス:
-36.64%
1年 パフォーマンス:
-69.06%
1日の値動き範囲:
$2.045
$2.15
1週間の範囲:
$1.78
$2.28
52週間の値動き範囲:
$1.31
$8.33
Nkarta Inc Stock (NKTX) Company Profile
名前
Nkarta Inc
セクター
電話
(925) 407-1049
住所
1150 VETERANS BOULEVARD, SOUTH SAN FRANCISCO
NKTX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
NKTX
Nkarta Inc
|
2.11 | 131.27M | 0 | -117.50M | -114.31M | -2.40 |
|
VRTX
Vertex Pharmaceuticals Inc
|
493.84 | 122.76B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
602.64 | 61.38B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
614.76 | 36.37B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
251.56 | 30.12B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
244.90 | 24.70B | 3.81B | -644.79M | -669.77M | -6.24 |
Nkarta Inc Stock (NKTX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-10-09 | 開始されました | Rodman & Renshaw | Buy |
| 2024-08-14 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2024-03-22 | ダウングレード | Raymond James | Strong Buy → Outperform |
| 2022-12-22 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2022-10-10 | 開始されました | Canaccord Genuity | Buy |
| 2022-07-28 | 開始されました | Needham | Buy |
| 2022-07-18 | 開始されました | SVB Leerink | Outperform |
| 2022-03-11 | 開始されました | Raymond James | Outperform |
| 2022-03-08 | 開始されました | H.C. Wainwright | Buy |
| 2022-01-06 | 開始されました | William Blair | Outperform |
| 2021-11-18 | 開始されました | SMBC Nikko | Outperform |
| 2021-07-16 | 開始されました | Oppenheimer | Outperform |
| 2020-08-04 | 開始されました | Cowen | Outperform |
| 2020-08-04 | 開始されました | Evercore ISI | Outperform |
| 2020-08-04 | 開始されました | Mizuho | Buy |
| 2020-08-04 | 開始されました | Stifel | Buy |
すべてを表示
Nkarta Inc (NKTX) 最新ニュース
A stock that deserves closer examination: Estrella Immunopharma Inc (ESLA) - uspostnews.com
Technical analysis of Nkarta Inc (NKTX) stock chart patterns - uspostnews.com
Market Momentum Report: Nkarta Inc (NKTX)’s Negative Close at 2.18 - DWinneX
Insider Sale Alert: Nkarta Inc [NKTX] – Is it Time to sell? - knoxdaily.com
A Tale of Resilience: Nkarta Inc Amid Stock Market Turbulence - investchronicle.com
Nkarta, Inc. (NASDAQ:NKTX) Receives Average Rating of “Buy” from Brokerages - Defense World
JPMorgan Chase & Co. Raises Stock Position in Nkarta, Inc. (NASDAQ:NKTX) - Defense World
Layoff Tracker: Mural Oncology Cuts 90% of Staff, Explores Strategic Alternatives - BioSpace
Nkarta (NKTX) Upgraded to Buy: Here's Why - NewsBreak: Local News & Alerts
Wellington Management Group LLP Boosts Stock Holdings in Nkarta, Inc. (NASDAQ:NKTX) - Defense World
Natural Killer Cell Therapy Market Hits New High | Major Giants Nkarta Therapeutics, Kiadis Pharma - newstrail.com
American Century Companies Inc. Buys 7,378 Shares of Nkarta, Inc. (NASDAQ:NKTX) - Defense World
Sei Investments Co. Invests $57,000 in Nkarta, Inc. (NASDAQ:NKTX) - Defense World
Nkarta’s (NKTX) Buy Rating Reiterated at Needham & Company LLC - Defense World
Nkarta (NASDAQ:NKTX) Earns "Buy" Rating from Needham & Company LLC - MarketBeat
Prudential Financial Inc. Sells 49,500 Shares of Nkarta, Inc. (NASDAQ:NKTX) - Defense World
CAR NK Expert With 25-Year Track Record Strengthens Senti Bio's Scientific Leadership - Stock Titan
Thrivent Financial for Lutherans Makes New Investment in Nkarta, Inc. (NASDAQ:NKTX) - Defense World
Charles Schwab Investment Management Inc. Cuts Stock Holdings in Nkarta, Inc. (NASDAQ:NKTX) - Defense World
Nkarta to Participate in an April Investor Conference - GlobeNewswire
NK Cell Pioneer Nkarta Takes Center Stage at Major Healthcare Conference - Stock Titan
Leerink Partnrs Has Bullish Outlook for Nkarta Q1 Earnings - The AM Reporter
Nkarta: Grinding Lower, Trying To Find Support (NASDAQ:NKTX) - Seeking Alpha
Nkarta: Betting On The Turnaround (NASDAQ:NKTX) - Seeking Alpha
What is HC Wainwright’s Forecast for Nkarta Q1 Earnings? - Defense World
William Blair Estimates Nkarta’s Q1 Earnings (NASDAQ:NKTX) - Defense World
Nkarta, Inc. (NASDAQ:NKTX) Receives $14.86 Average Price Target from Brokerages - Defense World
Stifel Nicolaus Has Lowered Expectations for Nkarta (NASDAQ:NKTX) Stock Price - Defense World
What is HC Wainwright’s Forecast for Nkarta Q4 Earnings? - Defense World
Needham & Company LLC Reaffirms “Buy” Rating for Nkarta (NASDAQ:NKTX) - Defense World
Nkarta’s Strategic Workforce Reduction and Clinical Progress Justify Buy Rating - TipRanks
Analysts Adjust Price Targets For Nkarta And Bicara - Evrim Ağacı
Why Is Autoimmune Disease Focused Nkarta Stock Trading Higher On Thursday? - Benzinga
Analysts Offer Insights on Healthcare Companies: Allurion Technologies (ALUR), Perspective Therapeutics (CATX) and Nkarta (NKTX) - The Globe and Mail
Nkarta to lay off staff, senior leadership, in bid to advance autoimmune cell therapy - BioPharma Dive
Stifel cuts Nkarta stock price target to $14, maintains buy rating - Investing.com India
Nkarta to lay off 34% of staff; Savara’s debt financing deal - Endpoints News
H.C. Wainwright maintains Buy on Nkarta stock with $18 target By Investing.com - Investing.com South Africa
H.C. Wainwright maintains Buy on Nkarta stock with $18 target - Investing.com
Nkarta lays off 3rd of staff to fund autoimmune CAR NK program - Fierce Biotech
Newly pivoted to autoimmune, Nkarta trims staff by over third - FirstWord Pharma
Nkarta’s Strategic Restructuring and NKX019 Progress Drive Buy Rating - TipRanks
Nkarta Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Highlights - GlobeNewswire
Nkarta Posts Narrower Q4 Loss; Discloses Restructuring Plan - Marketscreener.com
Nkarta Announces Major Restructuring and Leadership Changes - TipRanks
Nkarta Inc To Reduce Workforce By 34%, Impacting 53 PositionsSEC Filing - MarketScreener
Nkarta Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Nkarta's Strategic Reset: 34% Staff Cut Powers 5-Year Cash Runway with $380M War Chest - Stock Titan
Nkarta Inc (NKTX) 財務データ
収益
当期純利益
現金流量
EPS
0.24%
36.06%
大文字化:
|
ボリューム (24 時間):